Business Standard

Bleeding and clotting after Covid-19 vaccination minuscule: Govt report

The government decided to conduct an in-depth analysis of adverse events in India in light of global concerns, the health ministry said

Coronavirus vaccine, covid-19, vaccination
Premium

The AEFI data in India showed that there is a very miniscule but definitive risk of thromboembolic events

Ruchika Chitravanshi New Delhi
Bleeding and clotting cases following Covid-19 vaccination in India are minuscule but definitive and in line with the expected number of such diagnoses, a report submitted by the national committee on the Adverse Effects Following Immunisation (AEFI) on Monday said. 

The government decided to conduct an in-depth analysis of adverse events in India in light of global concerns, the health ministry said. Some countries on March 11 raised an alert on post-vaccination embolic and thrombotic events, particularly with AstraZeneca-Oxford vaccine — Covishield in India, the ministry said. 

The reporting rate of these events in India is around 0.61 per million doses, lower

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in